Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: 323990)
South Korea
· Delayed Price · Currency is KRW
10,440
-280 (-2.61%)
Dec 19, 2024, 3:00 PM KST
Vaxcell-Bio Therapeutics Revenue
Vaxcell-Bio Therapeutics had revenue of 29.24M KRW in the quarter ending June 30, 2024. This brings the company's revenue in the last twelve months to 69.60M. In the year 2023, Vaxcell-Bio Therapeutics had annual revenue of 13.72M.
Revenue (ttm)
69.60M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
229.93B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition